top of page
Create Your First Project
Start adding your projects to your portfolio. Click on "Manage Projects" to get started
Combination Potential
Because metabolic adaptation contributes to therapeutic resistance, MTX-101 is designed to integrate with:
• Standard-of-care chemotherapies
• Targeted therapies
• Immuno-oncology agents
By weakening tumor metabolic resilience, MTX-101 may enhance combination efficacy.
bottom of page

